Tuberculosis and diabetes mellitus - An underappreciated association

Archives of Medical Science

Volumn 10, Issue 5, 2014, Pages 1019-1027

  Skowroński, Marcin ^a   Zozulińska Ziólkiewicz, Dorota ^b   Barinow Wojewódzki, Aleksander ^a  

^a Wielkopolska Region Centre of Pulmonology and Thoracic Surgery   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Epidemic; Hyperglycemia; Mycobacterium tuberculosis; Screening

Indexed keywords

ANTIDIABETIC AGENT; TUBERCULOSTATIC AGENT;

ADAPTIVE IMMUNITY; ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYPERGLYCEMIA; INNATE IMMUNITY; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PROGNOSIS; RADIODIAGNOSIS; THERAPY EFFECT; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84908456844     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.46220     Document Type: Article

References (56)

1. Jeon C, Murray M. Diabetes mellitus inceases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5: e152.
2. Root H. The association of diabetes and tuberculosis. N Engl J Med 1934; 210: 1-13.
3. World Health Organization. Global Tuberculosis Report. WHO report 2012, Geneva 2012.
4. IDF Diabetes atlas. 5th ed. International Diabetes Federation, Brussels 2012.
5. Olayinka A, Anthonia O, Yetunde K. Prevalence of diabetes mellitus in persons with tuberculosis in a tertiary health centre in Lagos, Nigeria. Indian J Endocrinol Metab 2013; 17: 486-9.
6. Duangrithi D, Thanachartwet V, Desakorn V, et al. Impact of diabetes mellitus on clinical parameters and treatment outcomes of newly diagnosed pulmonary tuberculosis patients in Thailand. Int J Clin Pract 2013; 67: 1199-209.
7. Jiménez-Corona M, Cruz-Hervert L, Garcia-Garcia L, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 2013; 68: 214-20.
8. Gilhespy F, Holden H. Grave diabetes mellitus with pulmonary tuberculosis following mumps. Br J Med 1917; 2: 115.
9. Viswanathan V, Kumpatla S, Aravindalochanan V, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS Med 2012; 7: e41367.
10. Balakrishnan S, Vijayan S, Nair S, et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS Med 2012; 7: e46502
11. Gupta S, Shenoy V, Mukhopadhyay C, Bairy I, Muralidharan S. Role of risk factors and socio-economic status in pulmonary tuberculosis: a search for the root cause in patients in a tertiary care hospital, South India. Trop Med Int Health 2011; 16: 74-8.
12. Pablos-Méndez A, Blustein J, Knirsch C. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997; 87: 574-9.
13. Restrepo B, Camerlin A, Rahbar M, et al. Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bull World Health Organ 2011; 89: 352-9.
14. Corbett E, Watt C, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 169: 1009-21.
15. Restrepo B, Fisher-Hoch S, Smith B, Jeon S, Rahbar M, McCormick J. Short report: mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. Am J Trop Med Hyg 2008; 79: 541-4.
16. Alisjahbana B, van Crevel R, Sahiratmadja E, et al. Diabetes is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 2006; 10: 696-700.
17. Dye C, Trunz B, Lönnroth K, Roglic G, Williams B. Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS 2011; 6: e21161.
18. Bates M, O'Grady J, Mwaba P, et al. Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PLoS 2012; 7: e40774.
19. Faurholt-Jepsen D, Range N, PrayGod G, et al. Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PLoS 2011; 6: e24215.
20. Mugusi F, Swai A, Alberti K, McLarty D. Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle 1990; 71: 271-6.
21. Hall V, Thomsen R, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health 2011; 11: 564.
22. Dobler C, Flack J, Marks G. Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open 2012; 2: e000666.
23. Leung C, Lam T, Chan W, et al. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 2008; 167: 1486-94.
24. Walker C, Unwin N. Estimates of the impact of diabetes on the incidence of pulmonary tuberculosis in different ethnic groups in England. Thorax 2010; 65: 578-81.
25. Jick S, Lieberman E, Rahman M, et al. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 2006; 55: 19-26.
26. Leegaard A, Riis A, Kornum J, et al. Diabetes, glycemic control, and risk of tuberculosis. A population-based case-control study. Diabetes Care 2011; 34: 2530-5.
27. Webb E, Hesseling A, Schaaf H, et al. High prevalence of Mycobacterium tuberculosis infection and disease in children and adolescents with type 1 diabetes mellitus. Int J Tuberc Lung Dis 2009; 13: 868-74.
28. Basoglu O, Bacakoglu F, Cok G, Sayiner A, Ates M. The oral glucose tolerance test in patients with respiratory infections. Monadi Arch Chest Dis 1999; 54: 307-10.
29. Syed Suleiman SA, Ishaq Aweis DM, Mohamed AJ, Razakmuttalif A, Moussa MA. Role of diabetes in the prognosis and therapeutic outcome of tuberculosis. Int J Endocrinol 2012; 2012: 645362.
30. Tatar D, Senol G, Alptekin S, Karakurum C, Aydin M, Coskunol I. Tuberculosis in diabetics: features in an endemic area. Jpn J Infect Dis 2009; 62: 423-7.
31. Pérez-Guzmán C, Torres-Cruz A, Villarreal-Velarde H, Salazar-Lezama A, Vargas M. Atypical radiological images of pulmonary tuberculosis in 192 diabetic patients: a comparative study. Int J Tuberc Lung Dis 2001; 5: 455-61.
32. Pérez-Guzmán C, Torres-Cruz A, Villarreal-Velarde H, Vargas M. Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med 2000; 162: 1738-40.
33. Singla R, Khan N, Al-Sharif N, Al-Sayegh O, Shaikh M, Osman M. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 2006; 10: 74-9.
34. Hadlock F, Park S, Awe R, Rivera M. Unusual radiographic findings in adult pulmonary tuberculosis. AJR 1980; 134: 1015-8.
35. Alisjahbana B, Sahiratmadja E, Nelwan E, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. CID 2007; 45: 428-35.
36. Dooley K, Tang T, Golub J, Dorman S, Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 2009; 80: 634-639
37. Pérez-Guzmán C, Vargas M, Torres-Cruz A, Pérez-Padilla J, Furuya M, Villarreal-Velarde H. Diabetes modifies the male: female ratio in pulmonary tuberculosis. Int J Tuberc Lung Dis 2003; 7: 354-8.
38. Zhang Q, Xiao H, Sugawara I. Tuberculosis complicated by diabetes mellitus at Shanghai Pulmonary Hospital, China. Jpn J Infect Dis 2009; 62: 390-1.
39. Şahin F, Yildiz P. Distinctive biochemical changes in pulmonary tuberculosis and pneumonia. Arch Med Sci 2013; 9: 656-61.
40. Rekha V, Balasubramanian R, Swaminathan S, et al. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: an analysis of risk factors. Indian J Med Res 2007; 126: 452-8.
41. Chen Y, Chao J, Tsai C, Lee P, Perng R. Shortened survival of lung cancer patients initially presenting with pulmonary tuberculosis. Jpn J Clin Oncol 1996; 26: 322-327
42. Deng W, Yu M, Ma H, et al. Predictors and outcome of patients with acute respiratory distress syndrome caused by miliary tuberculosis: a retrospective study in Chongqing, China. BMC Infectious Diseases 2012; 12: 121.
43. Nijland H, Ruslami R, Stalenhoef J, et al. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis 2006; 43: 848-854
44. Ruslami R, Nijland H, Adhiarta G, et al. Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes. Antimicrob Agents Chemother 2010; 54: 1068-74.
45. Venkatesan K. Pharmacokinetic drug interactions with rifampicin. Clin Pharmacokinet 1992; 22: 47-65.
46. Chung-Delgado K, Revilla-Montag A, Guillen-Bravo S, et al. Factors associated with anti-tuberculosis medication adverse effects: a case-control study in Lima, Peru. PLoS 2011; 6: e27610.
47. API Consensus Expert Committee. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. J Assoc Physicians India 2006; 54: 219-34.
48. Wierusz-Wysocka B, Zozulińska-Ziólkiewicz D. Management of diabetes in emergencies and in special clinical situations [Polish]. Via Medica, Gdansk 2010.
49. Gomez D, Twahirwa M, Schlesinger L, Restrepo B. Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control. Tuberculosis 2013; 93: 192-7.
50. Vallerskog T, Martens G, Kornfeld H. Diabetic mice display adaptive immune response to Mycobacterium tuberculosis. J Immunol 2010; 184: 6275-82.
51. Restrepo B, Fisher-Hoch S, Pino P, et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. CID 2008; 47: 634-41.
52. Al-Attiyah R, Mustafa A. Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects. Clin Exp Immunol 2009; 158: 64-73.
53. Walsh M, Camerlin A, Miles R, et al. Sensitivity of Interferon-γ release assays is not compromised in tuberculosis patients with diabetes. Int J Tuberc Lung Dis 2011; 15: 179-iii.
54. Handel A, Ramagopalan S. Tuberculosis and diabetes mellitus: is vitamin D the missing link? Lancet 2010; 10: 596.
55. Skowroński M, Halicka A, Barinow-Wojewódzki A. New onset diabetes in a patient with active tuberculosis. Pneumonol Alergol Pol 2012; 80: 467-70.
56. Faurholt-Jepsen D, Range N, PrayGod G, et al. The role of anthropometric and other predictors for diabetes among urban Tanzanians with tuberculosis. Int J Tuberc Lung Dis 2012; 16: 1680-5.